M-Brain is now Valona in Global Rebrand
M-Brain, a global forerunner of competitive and market intelligence solutions, will evolve into Valona Intelligence. This powerful new identity leverages the company’s 20 years of experience, reflecting its position as a world leader in the Market and Competitive Intelligence space.
Valona’s hybrid intelligence approach uses AI at the core to provide impactful insights from over 200,000 business-focused global content sources, including those behind paywalls. Combining their proprietary AI technology with a team of industry-savvy analysts and customer strategists at the helm, Valona equips businesses with the tools needed to make impactful, informed decisions.
"Under the new identity of Valona, we're elevating market and competitive intelligence beyond generative AI," said Kimmo Havu, CEO at Valona. "By integrating AI with authentic, reliable content, alongside human analysis, we bridge the gap between raw data and actionable insights that fuel business decisions."
This distinctive blend equips Valona customers with a measurable competitive edge while enhancing their ability to identify market trends early.
"In contrast to many market competitors who are pure technology providers, we ensure our customers have comprehensive support,” Havu said. “Our toolkit, backed with our team's expertise, operationalizes insights to strategically target business needs, ensuring our customers stay ahead of their competition.”
"Our commitment to our customers goes beyond facilitating better decisions; we drive revenue growth. After all, what is greater than gaining more customers?” Havu said.
Valona continues to invest in its vision to make every business decision insights-driven at all levels of an organization. The introduction of a unique AI research assistant to the platform is further evidence of Valona’s commitment to maintaining its cutting-edge status. This new feature, launching later this year, will amplify organizations’ ability to perform faster, more precise analyses – just one highlight of the forward-thinking investments under the company’s renamed identity.
The rebrand underlines Valona’s status as a market leader, a recognition backed by The Forrester WaveTM: Market and Competitive Intelligence Platforms, Q2 2023 report. With an exceptional track record and a platform tailored for the future, Valona is set to redefine market and competitive intelligence.
About Valona
Valona Intelligence is the recognized leader in the market and competitive intelligence since 1999, formerly known as M-Brain. Combining the power of generative AI and analyst expertise, Valona provides businesses with the most crucial insights and to enable insights-driven decisions. Valona sends over 200,000 news alerts serving over 350,000 business users every day, with insights from hundreds of thousands of trusted industry-specific sources globally in over 100 languages. All translated into clean business summaries in English and presented in clear formats easy to share.
Having a global team across 9 offices in Americas, Europe, and Asia, Valona provides leading Fortune 500 with foresight to shape the future resulting in real business growth. Companies like Goodyear, Inspire Brands, Bosch, Philips, and Cintas have trusted M-Brain as their market intelligence solution, service, and content provider. Valona is acknowledged by Forrester in 2023 as the premier global platform for market and competitive intelligence. Discover more at www.valonaintelligence.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230912678029/en/
Contact information
Kati Tammisto
CMO, Valona
Kati.tammisto@valonaintelligence.com
+358 40 775 7162
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press Release
Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au
Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector15.12.2025 14:03:00 CET | Press Release
Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/ Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services. The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services. Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day. The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 20
Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 14:00:00 CET | Press Release
Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe rapidly transitions away from fossil fuels, the demand for residential heat pumps is growing in parallel with ambitious sustainabil
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom